Tobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA, NDC 62332-518-05
Published August 23, 2023 · Recall initiated: July 27, 2023
Summary
FDA records drug Class III recall D-1086-2023, published August 23, 2023 and initiated July 27, 2023. Recalling firm: ALEMBIC PHARMACEUTICALS, INC.; Status: Ongoing; Reported quantity: 82,400 bottles; Lot: Lot #: AMR103, Exp: 10/2023; Lot#: AMR201, Exp: 06/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if TOBRAMYCIN OPHTHALMIC SOLUTION has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TOBRAMYCIN OPHTHALMIC SOLUTION
- Manufacturer
- ALEMBIC PHARMACEUTICALS, INC.
- Distributor
- Nationwide in the USA
- Lot
- Lot #: AMR103, Exp: 10/2023; Lot#: AMR201, Exp: 06/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPLUVICTO 1,000MBq/mL (27 mCi/mL), lutetium Lu 177 vipivotide tetraxetan injection, 9.2 mL Single-dose vial,August 23, 2023
- FDATrader Joe's Fully Cooked Falafel Heat & Eat NET WT. 12 OZ (340g) Distributed and Sold Exclusively By: TraderAugust 23, 2023
- FDAhello wild strawberry fluoride toothpaste, sodium fluoride 0.24% (0.15% w/v fluoride ion), NET WT 4.2 OZ (119August 23, 2023
- FDAHeinen's Fresh Ground Cashew Butter: packaged in plastic circle containers 1lb. Sold individually.August 23, 2023
- FDAVEROCCA, Locally Handmade, ALFAJORAugust 23, 2023
- FDALINK MP Monoblock Hip Stem, Trial Stem Instruments, Size 25 - Indicated for patients with Mobility-limitingAugust 16, 2023
Questions about this recall
Was Tobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA, NDC 62332-518-05 recalled?
Yes. FDA published recall D-1086-2023 on August 23, 2023. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TOBRAMYCIN OPHTHALMIC SOLUTION.